Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study

Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study

Abstract Aims/Introduction Coronavirus disease 2019 (COVID‐19) vaccinations have been proven to be generally safe in healthy populations. However, the data on vaccine safety in patients with type 1 diabetes are scarce. This study aimed to evaluate the frequency and severity of short‐term (<7‐day)...

Full description

Bibliographic Details
Main Authors: Tulika Chatterjee, Naveen Ravichandran, Narmadha Nair, Abraham Edgar Gracia‐Ramos, Bhupen Barman, Parikshit Sen, Mrudula Joshi, Sreoshy Saha, Arvind Nune, Arun Kumar R Pande, Tsvetelina Velikova, Ioannis Parodis, Ai Lyn Tan, Samuel Katsuyuki Shinjo, Hiya Boro, Vikas Agarwal, Rohit Aggarwal, Latika Gupta, COVAD Study Group
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of Diabetes Investigation
Subjects:
COVID‐19
Type 1 diabetes mellitus
Vaccine
Online Access:https://doi.org/10.1111/jdi.14079

Internet

https://doi.org/10.1111/jdi.14079

Similar Items